Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Recombinant Protein / Other Proteins

Recombinant Human FSTL3 Protein, C-Fc

Catalog #:   EHB70601 Specific References (50) DATASHEET
Applications: ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress
Expression system: Mammalian Cells
Accession: O95633
Protein length: Met1-Val263
Overview

Catalog No.

EHB70601

Expression system

Mammalian Cells

Species

Homo sapiens (Human)

Protein length

Met1-Val263

Predicted molecular weight

54.06 kDa

Nature

Recombinant

Endotoxin level

Please contact with the lab for this information.

Purity

>90% as determined by SDS-PAGE.

Accession

O95633

Applications

ELISA, Immunogen, SDS-PAGE, WB, Bioactivity testing in progress

Form

Lyophilized

Storage buffer

Lyophilized from a solution in PBS pH 7.4, 1mM EDTA, 4% Trehalose, 1% Mannitol.

Reconstitution

Reconstitute in sterile water for a stock solution.A copy of datasheet will be provided with the products, please refer to it for details.

Shipping

In general, proteins are provided as lyophilized powder/frozen liquid. They are shipped out with dry ice/blue ice unless customers require otherwise.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.

Alternative Names

Follistatin-related gene protein, Follistatin-like protein 3, Follistatin-related protein 3, FLRG, FSTL3

Data Image
  • SDS-PAGE
    SDS PAGE for Recombinant Human FSTL3 Protein protein
References

Plasma Proteomics Reveals Dysregulated Pathways Across the Spectrum LMNA Cardiomyopathy., PMID:40509996

Activin B improves glucose metabolism via induction of Fgf21 and hepatic glucagon resistance., PMID:40246973

Upregulation of microRNA-3687 promotes gestational diabetes mellitus by inhibiting follistatin-like 3., PMID:40219801

FSTL3 promotes colorectal cancer by activating the HIF1 pathway., PMID:40154584

Multiomic traits reveal that critical irinotecan-related core regulator FSTL3 promotes CRC progression and affects ferroptosis., PMID:40140870

Circulating follistatin-like 3 and its association with postpartum cardiovascular dysfunction and severe maternal morbidity., PMID:40081190

Potential Plasma Proteins (LGALS9, LAMP3, PRSS8 and AGRN) as Predictors of Hospitalisation Risk in COVID-19 Patients., PMID:39334929

The comparative effect of teriparatide and denosumab on activins, follistatins, and inhibins in women with postmenopausal osteoporosis., PMID:38976019

Prognostic Significance of Proteomics-Discovered Circulating Inflammatory Biomarkers in Patients With Pulmonary Arterial Hypertension., PMID:38874078

Plasma proteomic biomarkers and the association between poor cardiovascular health and incident dementia: The UK Biobank study., PMID:38710337

Transforming growth factor-β signals promote progression of squamous cell carcinoma by inducing epithelial-mesenchymal transition and angiogenesis., PMID:38657447

GDF-8 improves in vitro implantation and cryo-tolerance by stimulating the ALK5-SMAD2/3 signaling in bovine IVF embryo development., PMID:38577502

Prenatal dexamethasone exposure impairs rat blood-testis barrier function and sperm quality in adult offspring via GR/KDM1B/FSTL3/TGFβ signaling., PMID:38472317

Endothelial Overexpression of TGF-β-Induced Protein Impairs Venous Thrombus Resolution: Possible Role in CTEPH., PMID:38362348

Large scale plasma proteomics identifies novel proteins and protein networks associated with heart failure development., PMID:38225249

Stroma-associated FSTL3 is a factor of calcium channel-derived tumor fibrosis., PMID:38044354

Development of a 5-mRNAsi-related gene signature to predict the prognosis of colon adenocarcinoma., PMID:38025763

High placental expression of FLT1, LEP, PHYHIP and IL3RA - In persons of African ancestry with severe preeclampsia., PMID:37949031

FSTL3 partially mediates the association of increased nonalcoholic fatty liver disease fibrosis risk with acute myocardial infarction in patients with type 2 diabetes mellitus., PMID:37904173

Circulating hormones in biopsy-proven steatotic liver disease and steatohepatitis: A Multicenter Observational Study., PMID:37757973

Prognostic Impact of FSTL3, ADAM12, and FAT4 in Patients of Colon Cancer: Clinicopathologic Study., PMID:37751246

Follistatin and follistatin-like 3 in metabolic disorders., PMID:37739334

Circulating Growth Differentiation Factors 11 and 8, Their Antagonists Follistatin and Follistatin-Like-3, and Risk of Heart Failure in Elders., PMID:37624693

Identification of potential biomarkers related to mesenchymal stem cell response in patients with Alzheimer's disease., PMID:37468918

Are follistatin-like protein 1 and follistatin-like protein 3 associated with inflammatory processes in patients with familial Mediterranean fever?, PMID:37435280

Gastrointestinal pharmacology activins in liver health and disease., PMID:37364623

Association of activins, follistatins and inhibins with incident hip fracture in women with postmenopausal osteoporosis: a proof of concept, case-control study., PMID:37221430

An integrated signature of extracellular matrix proteins and a diastolic function imaging parameter predicts post-MI long-term outcomes., PMID:37123479

Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension., PMID:37096577

Role of stemness-related genes TIMP1, PGF, and SNAI1 in the prognosis of colorectal cancer through single-cell RNA-seq., PMID:37017587

Construction and validation of a prognostic model based on ten signature cell cycle-related genes for early-stage lung squamous cell carcinoma., PMID:36938730

The cytoplasmic expression of FSTL3 correlates with colorectal cancer progression, metastasis status and prognosis., PMID:36807490

Evaluation of Associations of Growth Differentiation Factor-11, Growth Differentiation Factor-8, and Their Binding Proteins, Follistatin and Follistatin-Like Protein-3, With Measures of Skeletal Muscle Mass, Muscle Strength, and Physical Function in Older Adults., PMID:36752218

Evaluation of Associations of Growth Differentiation Factor-11, Growth Differentiation Factor-8, and Their Binding Proteins Follistatin and Follistatin-Like Protein-3 With Dementia and Cognition., PMID:36660892

Activins, follistatins and inhibins in postmenopausal osteoporosis: A proof of concept, case-control study., PMID:36587801

FSTL3 is highly expressed in adipose tissue of individuals with overweight or obesity and is associated with inflammation., PMID:36502285

Roles of follistatin-like protein 3 in human non-tumor pathophysiologies and cancers., PMID:36325361

A mechanistic framework for cardiometabolic and coronary artery diseases., PMID:36276926

Functional analysis of litter size and number of teats in pigs: From GWAS to post-GWAS., PMID:36209572

Prediction of Differentially Expressed Genes and a Diagnostic Signature of Preeclampsia via Integrated Bioinformatics Analysis., PMID:35711567

Identification of Significant Secreted or Membrane-Located Proteins in Laryngeal Squamous Cell Carcinoma., PMID:35655921

Plasma Proteomics of COVID-19-Associated Cardiovascular Complications: Implications for Pathophysiology and Therapeutics., PMID:35530264

Integrated Analysis Identifies Four Genes as Novel Diagnostic Biomarkers Which Correlate with Immune Infiltration in Preeclampsia., PMID:35528613

LINC00922 promotes deterioration of gastric cancer., PMID:35511773

Sex specificity of pancreatic cancer cachexia phenotypes, mechanisms, and treatment in mice and humans: role of Activin., PMID:35510530

microRNA-140-5p from human umbilical cord mesenchymal stem cells-released exosomes suppresses preeclampsia development., PMID:35484307

Copy Number Variation Analysis of Euploid Pregnancy Loss., PMID:35401693

Elevation of ADAM12 facilitates tumor progression by enhancing metastasis and immune infiltration in gastric cancer., PMID:35315496

Integrated RNA gene expression analysis identified potential immune-related biomarkers and RNA regulatory pathways of acute myocardial infarction., PMID:35231061

[Bioinformatics analysis of differently expressed genes in osteoblastic sarcoma and screening of key genes]., PMID:35184458

Datasheet
$ 480
Product specifications
100 μg 480 1 mg 2880

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Recombinant Human FSTL3 Protein, C-Fc [EHB70601]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only